Evidence map›Paper›PMID 36880056›Full record

ArticleIBRO neuroscience reports2023

Pathways to healing: Plants with therapeutic potential for neurodegenerative diseases.

Sheena E B Tyler, Luke D K Tyler

Abstract read
In one paragraph

Article in IBRO neuroscience reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Modulatory Effects ofAntioxidants (Basel, Switzerland) · 2025
    Review
  3. Therapeutic Effects ofInternational journal of molecular sciences · 2025
    Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. GenusInternational journal of molecular sciences · 2024
    Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sheena E B TylerJohn Ray Research Field Station, Cheshire, United Kingdom.
Luke D K TylerSchool of Natural Sciences, Bangor University, Gwynedd, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Some of the greatest challenges in medicine are the neurodegenerative diseases (NDs), which remain without a cure and mostly progress to death. A companion study employed a toolkit methodology to document 2001 plant species with ethnomedicinal uses for alleviating pathologies relevant to NDs, focusing on its relevance to Alzheimer's disease (AD). This study aimed to find plants with therapeutic bioactivities for a range of NDs. 1339 of the 2001 plant species were found to have a bioactivity from the literature of therapeutic relevance to NDs such as Parkinson's disease, Huntington's disease, AD, motor neurone diseases, multiple sclerosis, prion diseases, Neimann-Pick disease, glaucoma, Friedreich's ataxia and Batten disease. 43 types of bioactivities were found, such as reducing protein misfolding, neuroinflammation, oxidative stress and cell death, and promoting neurogenesis, mitochondrial biogenesis, autophagy, longevity, and anti-microbial activity. Ethno-led plant selection was more effective than random selection of plant species. Our findings indicate that ethnomedicinal plants provide a large resource of ND therapeutic potential. The extensive range of bioactivities validate the usefulness of the toolkit methodology in the mining of this data. We found that a number of the documented plants are able to modulate molecular mechanisms underlying various key ND pathologies, revealing a promising and even profound capacity to halt and reverse the processes of neurodegeneration.

Indexed as

AD, Alzheimer’s diseaseA-H, Alpers-Huttenlocher syndromeALS, Amyotrophic lateral sclerosisBBB, blood-brain barrierC. elegans,, Caenorhabditis elegansCJD, Creutzfeldt-Jakob diseaseCMT, Charcot–Marie–Tooth diseaseCS, Cockayne syndromeEch A, Echinochrome AFDA, Food and Drug AdministrationFRDA, Friedreich’s ataxiaFTD, Frontotemporal dementiaHD, Huntington’s diseaseHsp, Heat shock proteinLSD, Lysosomal storage diseasesMedicinal plantMSA, Multiple system atrophyMS, Multiple sclerosisMSP, Multisystem proteinopathyND, neurodegenerative diseaseNeurodegenerationNeurogenesisNeuro-inflammationNPC, Neimann-Pick disease type CNSC, neural stem cellsPC, pharmacological chaperonePD, Parkinson’s diseaseprion dis, prion diseasesProtein misfoldingSMA, Spinal muscular atrophyVD, Vascular dementiaα-syn, alpha-synuclein

Identifiers

PMID36880056
PMCPMC9984566

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.